DE278884C - - Google Patents
Info
- Publication number
- DE278884C DE278884C DENDAT278884D DE278884DA DE278884C DE 278884 C DE278884 C DE 278884C DE NDAT278884 D DENDAT278884 D DE NDAT278884D DE 278884D A DE278884D A DE 278884DA DE 278884 C DE278884 C DE 278884C
- Authority
- DE
- Germany
- Prior art keywords
- methyl
- aryl
- chloromethylimidazole
- ecm
- condensation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 150000003142 primary aromatic amines Chemical class 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims 1
- 238000006011 modification reaction Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 150000004982 aromatic amines Chemical class 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N Imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 210000001772 Blood Platelets Anatomy 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 229940041158 antibacterial for systemic use Imidazole derivatives Drugs 0.000 description 1
- 229940042051 antimycotic for systemic use Imidazole derivatives Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000249 desinfective Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940093910 gyncological antiinfectives Imidazole derivatives Drugs 0.000 description 1
- 230000001631 hypertensive Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000000977 initiatory Effects 0.000 description 1
- 229940079865 intestinal antiinfectives Imidazole derivatives Drugs 0.000 description 1
- 230000002147 killing Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical class [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE278884C true DE278884C (fr) |
Family
ID=534847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT278884D Active DE278884C (fr) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE278884C (fr) |
-
0
- DE DENDAT278884D patent/DE278884C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2634288A1 (de) | Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE1132784B (de) | Konservieren von Pflanzenmaterial mittels Adeninderivaten | |
| DE278884C (fr) | ||
| DE506282C (de) | Verfahren zur Darstellung hochalkylierter Guanidine | |
| DE2542791C2 (de) | N,N'-Disubstituierte Naphthylacetamidine | |
| DE940292C (de) | Verfahren zur Herstellung von Stickstoff und Schwefel enthaltenden Kondensationsprodukten | |
| DE1154119B (de) | Verfahren zur Herstellung von 2-(2', 4', 6'-Trimethylbenzyl)-1, 3-diazacyclopenten-(2) und seinen Salzen | |
| DE2166270C3 (de) | Nicotinoylaminoäthansulfonyl-2amino-thiazol | |
| DE164425C (fr) | ||
| DE276541C (fr) | ||
| DE1177631B (de) | Verfahren zur Herstellung von N-substituierten Benzolsulfonyl-N'-cyclohexyl- oder heptylharn-stoffen | |
| DE756489C (de) | Verfahren zur Herstellung von C-Cycloheptenylbarbitursaeuren | |
| DE743467C (de) | Verfahren zur Herstellung von Nicotinsaeure-alkaminestern | |
| DE1119263B (de) | Verfahren zur Herstellung neuer Sulfonylurethane | |
| DE1768787C3 (de) | (o-Carboxy-phenyl)-acetamidine, Verfahren zu deren Herstellung und (o-CarboxyphenyO-acetamidine enthaltende Präparate | |
| DE317668C (fr) | ||
| DE1620490C (de) | Pyrazolon-(5)-derivate und ein Verfahren zu ihrer Herstellung | |
| DE247270C (fr) | ||
| AT126139B (de) | Verfahren zur Darstellung basischer Nitroderivate des 9-Aminoacridins. | |
| DE1795309B2 (de) | 2,4-Diamino-6-acylamino-chinazolinverbindungen und Verfahren zu ihrer Herstellung | |
| DE1100637B (de) | Verfahren zur Herstellung von Alkyleniminoalkylguanidinen, deren Acylverbindungen, Salzen und quaternaeren Ammoniumverbindungen | |
| DE2214488A1 (de) | Verfahren zur Herstellung 1-substituierter 4-Aminopyrrolin-3-one-(2) | |
| DE343323C (fr) | ||
| DE2153869C3 (de) | N-substituierte epsilon-Guanidinosäureamide und diese enthaltende Arzneimittelzusa mmensetzung | |
| DE1098001B (de) | Verfahren zur Herstellung von N-(Diaethylaminoalkyl)-salicylamiden |